Related references
Note: Only part of the references are listed.Innovative organotypic in vitro models for safety assessment: aligning with regulatory requirements and understanding models of the heart, skin, and liver as paradigms
Chris S. Pridgeon et al.
ARCHIVES OF TOXICOLOGY (2018)
In vitro and in vivo imaging and tracking of intestinal organoids from human induced pluripotent stem cells
Kwang Bo Jung et al.
FASEB JOURNAL (2018)
Interleukin-2 induces the in vitro maturation of human pluripotent stem cell-derived intestinal organoids
Kwang Bo Jung et al.
NATURE COMMUNICATIONS (2018)
Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient-derived induced pluripotent stem cells
M. -Y. Son et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2017)
Metabolic zonation of the liver: The oxygen gradient revisited
Thomas Kietzmann
REDOX BIOLOGY (2017)
Dual modulation of human hepatic zonation via canonical and non-canonical Wnt pathways
Laura McEnerney et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
GSK-3β Inhibitor CHIR-99021 Promotes Proliferation Through Upregulating β-Catenin in Neonatal Atrial Human Cardiomyocytes
Shoubao Wang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2016)
Orchestrating Wnt signalling for metabolic liver zonation
Walter Birchmeier
NATURE CELL BIOLOGY (2016)
Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting
Xuanyi Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Characterization of a functional C3A liver spheroid model
Harriet Gaskell et al.
TOXICOLOGY RESEARCH (2016)
Isoniazid metabolism and hepatotoxicity
Pengcheng Wang et al.
ACTA PHARMACEUTICA SINICA B (2016)
A Microfabricated Platform for Generating Physiologically-Relevant Hepatocyte Zonation
William J. McCarty et al.
SCIENTIFIC REPORTS (2016)
Analysis of Glycogen Synthase Kinase Inhibitors That Regulate Cytochrome P450 Expression in Primary Human Hepatocytes by Activation of β-Catenin, Aryl Hydrocarbon Receptor and Pregnane X Receptor Signaling
Philippe Briolotti et al.
TOXICOLOGICAL SCIENCES (2015)
Activating and Inhibitory Functions of WNT/β-Catenin in the Induction of Cytochromes P450 by Nuclear Receptors in HepaRG Cells
Maria Thomas et al.
MOLECULAR PHARMACOLOGY (2015)
Differentiation of liver progenitor cell line to functional organotypic cultures in 3D nanofibrillar cellulose and hyaluronan-gelatin hydrogels
Melina M. Malinen et al.
BIOMATERIALS (2014)
Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma
Eleanor Y. Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The WNT/β-Catenin Pathway Is a Transcriptional Regulator of CYP2E1, CYP1A2, and Aryl Hydrocarbon Receptor Gene Expression in Primary Human Hepatocytes
Sabine Gerbal-Chaloin et al.
MOLECULAR PHARMACOLOGY (2014)
Wnt/β-catenin signalling: from plasma membrane to nucleus
Wantae Kim et al.
BIOCHEMICAL JOURNAL (2013)
Hydrogel-based diffusion chip with Electric Cell-substrate Impedance Sensing (ECIS) integration for cell viability assay and drug toxicity screening
Trong Binh Tran et al.
BIOSENSORS & BIOELECTRONICS (2013)
3D Organotypic Cultures of Human HepaRG Cells: A Tool for In Vitro Toxicity Studies
Patrina Gunness et al.
TOXICOLOGICAL SCIENCES (2013)
Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins
H. H. J. Gerets et al.
CELL BIOLOGY AND TOXICOLOGY (2012)
Role of Biotransformation in Drug-Induced Toxicity: Influence of Intra-and Inter-Species Differences in Drug Metabolism
Thomas A. Baillie et al.
DRUG METABOLISM AND PHARMACOKINETICS (2011)
HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro
Marc Luebberstedt et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2011)
Stable Expression, Activity, and Inducibility of Cytochromes P450 in Differentiated HepaRG Cells
Sebastien Antherieu et al.
DRUG METABOLISM AND DISPOSITION (2010)
The human hepatoma HepaRG cells: A highly differentiated model for studies of liver metabolism and toxicity of xenobiotics
Andre Guillouzo et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2007)
Primary hepatocytes: Current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies
Nicola J. Hewitt et al.
DRUG METABOLISM REVIEWS (2007)
The Wnt/β-catenin pathway:: master regulator of liver zonation?
Zoe D. Burke et al.
BIOESSAYS (2006)
Apc tumor suppressor gene is the zonation-keeper of mouse liver
Samira Benhamouche et al.
DEVELOPMENTAL CELL (2006)
In vitro zonation and toxicity in a hepatocyte bioreactor
JW Allen et al.
TOXICOLOGICAL SCIENCES (2005)
Do preclinical testing strategies help predict human hepatotoxic potentials?
TS Peters
TOXICOLOGIC PATHOLOGY (2005)
Medical progress: Drug-induced hepatotoxicity
WM Lee
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Formation of steady-state oxygen gradients in vitro - Application to liver zonation
JW Allen et al.
BIOTECHNOLOGY AND BIOENGINEERING (2003)
Induction of cytochrome P4502B6 and 3A4 expression by phenobarbital and cyclophosphamide in cultured human liver slices
H Martin et al.
PHARMACEUTICAL RESEARCH (2003)
Influence of culture time on the expression of drug-metabolizing enzymes in primary human hepatocytes and hepatoma cell line HepG2
S Wilkening et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2003)
Concordance of the toxicity of pharmaceuticals in humans and in animals
H Olson et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2000)
Oxygen: Modulator of metabolic zonation and disease of the liver
K Jungermann et al.
HEPATOLOGY (2000)
Share Paper
